The Cancer Letter

Inside information on cancer research and drug development

Vol.
29
No.
8
February 21, 2003Feb 21, 2003
Free
DOWNLOAD THE PDF

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

ODAC Reviews Post-Marketing Studies for Eight Indications

Georgetown Sponsors Oncology Agent Development Meeting

Bush Appoints Kripke To President’s Cancer Panel

Letter to the Editor

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account